Abstract
Patients with acute myeloid leukemia (AML) may differ significantly in their response to therapy and long-term outcome. A number of risk factors have been identified that characterize patients at diagnosis as well as during their clinical course. At diagnosis these parameters include age, cytogenetic configuration, hemopoietic elements, and a previous history of myelodysplasia or cytoreductive therapy for a preexisting malignancy. They are complemented by the response to induction therapy and subsequent treatments as well as by the duration of response. More recently, gene expression profiling of leukemic cells has added a new dimension to simultaneously assess biological risk factors that may ultimately lead to individualization of therapy. This presentation will review data to address the question of whether or not allogeneic transplants are effective in the management of patients with AML presenting with adverse cytogenetics and older age, showing a poor response to induction therapy, and relapsing after achieving a remission.
References
Sep 30, 1998·British Journal of Haematology·S KeatingR A Zittoun
Aug 25, 2001·Blood·D GrimwadeUNKNOWN Medical Research Council Adult Leukemia Working Party
Jun 19, 2002·Blood·Susanne SchnittgerWolfgang Hiddemann
Jul 26, 2002·British Journal of Haematology·Alan K BurnettUNKNOWN Medical Research Council Adult and Paediatric Working Parties
Sep 18, 2002·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Yves ChalandonDonna E Hogge
Jan 23, 2003·Leukemia Research·Emmanuelle TavernierXavier Thomas
Apr 17, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hartmut BertzJürgen Finke
Apr 26, 2003·Blood·Stefan SuciuUNKNOWN EORTC and GIMEMA Leukemia Groups
Oct 31, 2003·Leukemia·C SchochT Haferlach
Dec 17, 2003·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·H C FungS J Forman
Dec 2, 2004·Blood·Joseph O MooreCharles A Schiffer
Jan 6, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dimitri A BreemsBob Löwenberg
Mar 3, 2005·Cancer·Masamitsu YanadaTomoki Naoe
May 4, 2005·Blood·Alexandros SpyridonidisJürgen Finke
Jun 17, 2005·Leukemia·M YanadaT Naoe
Dec 25, 2007·Blood·Vinod PullarkatFrederick R Appelbaum
Citations
Apr 14, 2009·Bone Marrow Transplantation·U BacherT Haferlach
Apr 5, 2011·Haematologica·Matthias StelljesUNKNOWN German AML Cooperative Group (AMLCG)
Oct 13, 2007·Blood Cells, Molecules & Diseases·Maria De IoanniAntonio Tabilio
Oct 18, 2006·European Journal of Haematology·Assunta ViolaFelicetto Ferrara
Jul 25, 2009·Deutsches Ärzteblatt International·Axel Rolf ZanderJürgen Finke